|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Vasomotor Symptoms | |||||
| 2 | Interventions listed in this trial | ||||
| Placebo | |||||
| 3 | Additional drug interventions recognized in this trial | ||||
| Drospirenone | |||||
| Estradiol | |||||
| 4 | More general drug interventions related to this trial | ||||
| Aldosterone Antagonists | |||||
| Estrogens | |||||
| Hormone Antagonists | |||||
| Hormones | |||||
| Hormones, Hormone Substitutes, and Hormone Antagonists | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| 5 | Sponsors listed in this trial | ||||
| Bayer | |||||